Eriodictyol targets the ubiquitination/phosphorylation of apoptosis signal‐regulating kinase 1 and alleviates pressure‐overload induced myocardial fibrosis in mice
British Journal of Pharmacology · 2026-12 · 183 (23) · 6966-6987
DOI: 10.1111/bph.70648 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 26.08.2026. Verfasst von Yu-Ting Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Flavanones, MAP Kinase Kinase Kinase 5, Myocardium, Cardiomyopathies. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Regional Innovation and Development Joint Fund of National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and purpose Myocardial fibrosis, a critical pathogenic driver of cardiovascular events, is primarily characterized by extracellular matrix deposition and cardiac fibroblast proliferation and activation. Eriodictyol (ERIO) is an extractable natural compound widely found in fruits and vegetables, possessing positive antioxidant and anti‐inflammatory benefits. This study primarily explores the role and molecular mechanism of ERIO in pressure overload‐induced myocardial fibrosis. Experimental approach We established an in vivo cardiac remodelling model using transverse aortic constriction (TAC) surgery and an in vitro myocardial fibrosis model induced by transforming growth factor β (TGF‐ β ). For mechanistic exploration, we administered adeno‐associated virus (AAV) carrying cardiac fibroblast‐specific apoptosis signal‐regulating kinase 1 (ASK1) overexpression via tail vein injection, generated a cardiac fibroblast‐specific ASK1 knockout mouse model, and established an in vitro neonatal rat cardiac fibroblast (NRCF) model with co‐intervention of the selective ASK1 inhibitor GS‐4977. Key results ERIO significantly improved pressure overload‐induced cardiac dysfunction and myocardial fibrosis. In addition, ERIO inhibited oxidative stress and inflammatory responses and improved mitochondrial function. Specifically, our mechanistic study revealed that ERIO binds to the K398 site of ASK1, regulating its ubiquitination and phosphorylation activation, down‐regulating its downstream JNK/P38 signalling axis and inhibiting the proliferation and activation of cardiac fibroblasts. Conclusions and implications ERIO is a safe, effective natural flavonoid with promising preclinical efficacy, suggesting its potential clinical translation for myocardial fibrosis and offering new therapeutic targets to prevent heart failure progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
- Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, China.
ORCID-Profile: Yu-Ting Liu, Yan Che, Ya-Jia Ding, Hong-Liang Qiu, Yuan Yuan, Qi-Zhu Tang
Förderung
- Regional Innovation and Development Joint Fund of National Natural Science Foundation of China
Zitieren
APA
Liu, Y. T., Che, Y., Ding, Y. J., Qiu, H. L., Yuan, Y., & Tang, Q. Z. (2026). Eriodictyol targets the ubiquitination/phosphorylation of apoptosis signal‐regulating kinase 1 and alleviates pressure‐overload induced myocardial fibrosis in mice. British Journal of Pharmacology, 183(23), 6966-6987. https://doi.org/10.1111/bph.70648
Vancouver
Liu YT, Che Y, Ding YJ, Qiu HL, Yuan Y, Tang QZ. Eriodictyol targets the ubiquitination/phosphorylation of apoptosis signal‐regulating kinase 1 and alleviates pressure‐overload induced myocardial fibrosis in mice. British Journal of Pharmacology. 2026;183(23):6966-6987. doi:10.1111/bph.70648
BibTeX
@article{Liu2026,
author = {Liu, Yu-Ting and Che, Yan and Ding, Ya-Jia and Qiu, Hong-Liang and Yuan, Yuan and Tang, Qi-Zhu},
title = {Eriodictyol targets the ubiquitination/phosphorylation of apoptosis signal‐regulating kinase 1 and alleviates pressure‐overload induced myocardial fibrosis in mice},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {23},
pages = {6966--6987},
doi = {10.1111/bph.70648}
}
EUVIMED